[1][2] Science 37 was founded in 2014[3] by Noah Craft and Belinda Tan, working out of LA BioMed at Harbor-UCLA Medical Center.

[5] The platform also aided researchers in finding and contacting potential participants, and scheduling trial participants for in-home activities like questionnaires, mobile nurse visits,[6] and door-step study medicine delivery.

[9][10] In March 2019, Science 37 secured $35 million in Series D funding; and announced a leadership transition with David Coman coming in as CEO in November 2019.

[5] That year Science 37 also began planning site-less trials for Sanofi[12] and Otsuka Pharmaceutical.

[14] Science 37 was already in the process of conducting trials with Novartis in acne, cluster headaches, and fatty liver disease.